Our weekly podcast from Politics Home discussing all the ups and downs in Westminster. Please subscribe and share - and keep up with all the latest news on PoliticsHome.com. Got a question for the team? news@politicshome.com.
…
continue reading
Content provided by Africa Business Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Africa Business Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
UN Agency To Manufacture Covid-19 Pills for Poor Nations
MP3•Episode home
Manage episode 318175796 series 2902121
Content provided by Africa Business Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Africa Business Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
A United Nations-backed agency, Medicines Patent Pool, has struck a deal for nearly 30 generic drug makers to manufacture low-cost versions of Merck & Co’s COVID-19 pill, molnupiravir for poorer nations.
A Reuters report stated that the deal, negotiated by the UN-backed organisation with Merck, would expand output by increasing the number of companies that would produce the drug.
The new agreement allows 27 generic drug makers from India, China and other countries in Africa, Asia and the Middle East to produce ingredients and the finished drug.
The MPP stated that the deal stipulated that the pill would be distributed to 105 less-developed nations.
…
continue reading
A Reuters report stated that the deal, negotiated by the UN-backed organisation with Merck, would expand output by increasing the number of companies that would produce the drug.
The new agreement allows 27 generic drug makers from India, China and other countries in Africa, Asia and the Middle East to produce ingredients and the finished drug.
The MPP stated that the deal stipulated that the pill would be distributed to 105 less-developed nations.
1000 episodes
MP3•Episode home
Manage episode 318175796 series 2902121
Content provided by Africa Business Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Africa Business Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
A United Nations-backed agency, Medicines Patent Pool, has struck a deal for nearly 30 generic drug makers to manufacture low-cost versions of Merck & Co’s COVID-19 pill, molnupiravir for poorer nations.
A Reuters report stated that the deal, negotiated by the UN-backed organisation with Merck, would expand output by increasing the number of companies that would produce the drug.
The new agreement allows 27 generic drug makers from India, China and other countries in Africa, Asia and the Middle East to produce ingredients and the finished drug.
The MPP stated that the deal stipulated that the pill would be distributed to 105 less-developed nations.
…
continue reading
A Reuters report stated that the deal, negotiated by the UN-backed organisation with Merck, would expand output by increasing the number of companies that would produce the drug.
The new agreement allows 27 generic drug makers from India, China and other countries in Africa, Asia and the Middle East to produce ingredients and the finished drug.
The MPP stated that the deal stipulated that the pill would be distributed to 105 less-developed nations.
1000 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.